Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

Pain measures and cut-offs - ‘no worse than mild pain’ as a simple, universal outcome

(2013) R. A. Moore et al.   ANAESTHESIA

Duloxetine use in chronic painful conditions - individual patient data responder analysis

(2013) R.A. Moore et al.   EUROPEAN JOURNAL OF PAIN

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Addictive behaviors related to opioid use for chronic pain: A population-based study

(2013) Jette Hjsted et al.   PAIN

Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis

(2013) Shannon Cope et al.   RESPIRATORY RESEARCH

Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit-Risk

(2013) Robert Andrew Moore et al.   Pain Practice

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis

(2012) A.B. Hauber et al.   OSTEOARTHRITIS AND CARTILAGE

The burden of chronic pain: A cross-sectional survey focussing on diseases, immigration, and opioid use

(2012) Geana Paula Kurita et al.   PAIN

Pain as a global public health priority

(2011) Daniel S Goldberg et al.   BMC PUBLIC HEALTH

Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials

(2011) F Salvo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A comparison of the therapeutic efficacy of diclofenac in osteoarthritis: a systematic review of randomised controlled trials

(2011) K. Pavelka   CURRENT MEDICAL RESEARCH AND OPINION

Osteoarthritis: an update with relevance for clinical practice

(2011) Johannes WJ Bijlsma et al.   LANCET

Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

(2011) Andrew R. Moore et al.   PAIN

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

(2011) David C. Hoaglin et al.   VALUE IN HEALTH

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

(2011) Jeroen P. Jansen et al.   VALUE IN HEALTH

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT

(2010) A. D. Sawitzke et al.   ANNALS OF THE RHEUMATIC DISEASES

Application of the BRAT Framework to Case Studies: Observations and Insights

(2010) B S Levitan et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit–Risk Balance of Medicines

(2010) P M Coplan et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

OARSI recommendations for the management of hip and knee osteoarthritis

(2010) W. Zhang et al.   OSTEOARTHRITIS AND CARTILAGE

Chronic low back pain analgesic studies – A methodological minefield

(2010) Andrew R. Moore et al.   PAIN

Numbers-needed-to-treat analyses – Do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials

(2010) Andrew R. Moore et al.   PAIN

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

(2009) R A Moore et al.   ANNALS OF THE RHEUMATIC DISEASES

Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)

(2009) B. Combe et al.   RHEUMATOLOGY

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN